SEC Form 13F
| Report period | 2026-06-30 |
|---|---|
| Publicly available | 2026-07-23 |
| Reported value | $147,284,336 |
| Positions | 3 |
| Issuer | Ticker | Class | Reported value | Reported amount |
|---|---|---|---|---|
| BICARA THERAPEUTICS INC | BCAX | COM | $93,924,820 | 3,163,517 |
| CERIBELL INC | CBLL | COM | $42,900,106 | 2,205,661 |
| CONTINEUM THERAPEUTICS INC | CTNM | CL A | $10,459,410 | 638,158 |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.